Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-054016

Cascadian Therapeutics, Inc. · CASC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 24, 2017
Accepted (ET)
Sep 26, 2017 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412067

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 24, 2017M2,375$0.00A14,271D
Common StockF1Sep 24, 2017F594$3.94D13,677D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Share Unit (RSU)F2,F3—Sep 24, 2017M2,375D——Common Stock2,3750D

Explanation of responses